DK0866800T3 - Antineoplastiske peptider - Google Patents

Antineoplastiske peptider

Info

Publication number
DK0866800T3
DK0866800T3 DK96943076T DK96943076T DK0866800T3 DK 0866800 T3 DK0866800 T3 DK 0866800T3 DK 96943076 T DK96943076 T DK 96943076T DK 96943076 T DK96943076 T DK 96943076T DK 0866800 T3 DK0866800 T3 DK 0866800T3
Authority
DK
Denmark
Prior art keywords
antineoplastic peptides
antineoplastic
peptides
Prior art date
Application number
DK96943076T
Other languages
Danish (da)
English (en)
Inventor
Wilhelm Amberg
Teresa Barlozzari
Andreas Kling
Kurt Ritter
Thomas Zierke
Harald Bernard
Ernst Buschmann
Andreas Haupt
Hans-Guenther Hege
Bernd Janssen
Helmut Lietz
Martina Ullrich
Juergen Weymann
Original Assignee
Abbott Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Gmbh & Co Kg filed Critical Abbott Gmbh & Co Kg
Application granted granted Critical
Publication of DK0866800T3 publication Critical patent/DK0866800T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/10General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using coupling agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK96943076T 1995-12-15 1996-12-11 Antineoplastiske peptider DK0866800T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57342295A 1995-12-15 1995-12-15
PCT/EP1996/005518 WO1997022621A2 (en) 1995-12-15 1996-12-11 Antineoplastic peptides

Publications (1)

Publication Number Publication Date
DK0866800T3 true DK0866800T3 (da) 2005-01-17

Family

ID=24291935

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96943076T DK0866800T3 (da) 1995-12-15 1996-12-11 Antineoplastiske peptider

Country Status (30)

Country Link
EP (2) EP0866800B1 (de)
JP (1) JP3939354B2 (de)
KR (1) KR100463739B1 (de)
CN (1) CN1127514C (de)
AR (1) AR004382A1 (de)
AT (2) ATE471944T1 (de)
AU (2) AU731458B2 (de)
BG (1) BG64563B1 (de)
BR (1) BR9611987A (de)
CA (1) CA2237721C (de)
CO (1) CO4750840A1 (de)
CZ (1) CZ296908B6 (de)
DE (2) DE69638206D1 (de)
DK (1) DK0866800T3 (de)
ES (1) ES2229287T3 (de)
HR (1) HRP960585A2 (de)
HU (1) HU228275B1 (de)
IL (2) IL124342A (de)
MX (1) MX9803953A (de)
MY (1) MY114327A (de)
NO (1) NO319273B1 (de)
NZ (1) NZ324691A (de)
PL (1) PL186721B1 (de)
PT (1) PT866800E (de)
RU (1) RU2182911C2 (de)
SK (1) SK285286B6 (de)
TR (1) TR199801102T2 (de)
TW (1) TW474946B (de)
WO (1) WO1997022621A2 (de)
ZA (1) ZA9610510B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6143721A (en) 1997-07-18 2000-11-07 Basf Aktiengesellschaft Dolastatin 15 derivatives
US5985837A (en) * 1998-07-08 1999-11-16 Basf Aktiengesellschaft Dolastatin 15 derivatives
CA2360740A1 (en) 1999-03-02 2000-09-08 Boehringer Ingelheim Pharmaceuticals, Inc. Compounds useful as reversible inhibitors of cathepsin s
US6420364B1 (en) 1999-09-13 2002-07-16 Boehringer Ingelheim Pharmaceuticals, Inc. Compound useful as reversible inhibitors of cysteine proteases

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879276A (en) * 1983-12-19 1989-11-07 Uniroyal Chemical Ltd./Uniroyal Chemical Ltee Method for reducing serum uric acid levels
US4816444A (en) * 1987-07-10 1989-03-28 Arizona Board Of Regents, Arizona State University Cell growth inhibitory substance
US5831002A (en) * 1992-05-20 1998-11-03 Basf Aktiengesellschaft Antitumor peptides
AU669710B2 (en) * 1992-05-20 1996-06-20 Abbott Gmbh & Co. Kg Derivatives of dolastatin
ATE196296T1 (de) * 1992-12-16 2000-09-15 Basf Ag Dolastatin analog
DE4415997A1 (de) * 1994-05-06 1995-11-09 Basf Ag Neuer peptidischer Wirkstoff und dessen Herstellung
DE4415998A1 (de) * 1994-05-06 1995-11-09 Basf Ag Neue Tetrapeptide, ihre Herstellung Verwendung
US5807984A (en) * 1995-11-09 1998-09-15 Basf Aktienegesellschaft Oligopeptides, the preparation and use thereof

Also Published As

Publication number Publication date
EP0866800B1 (de) 2004-09-22
WO1997022621A3 (en) 1998-02-26
AU2004220772B2 (en) 2008-06-12
ATE277076T1 (de) 2004-10-15
JP2000502092A (ja) 2000-02-22
CA2237721C (en) 2008-01-29
MX9803953A (es) 1998-09-30
DE69638206D1 (de) 2010-08-05
HRP960585A2 (en) 1998-02-28
DE69633457T2 (de) 2005-09-22
AU1192597A (en) 1997-07-14
BG102479A (en) 1999-06-30
SK76798A3 (en) 1999-02-11
CN1204342A (zh) 1999-01-06
DE69633457D1 (de) 2004-10-28
NO982711D0 (no) 1998-06-12
AU2004220772A1 (en) 2004-11-11
ES2229287T3 (es) 2005-04-16
AU731458B2 (en) 2001-03-29
NO319273B1 (no) 2005-07-11
IL124342A0 (en) 1998-12-06
HUP0000172A3 (en) 2000-09-28
EP1593686A1 (de) 2005-11-09
CA2237721A1 (en) 1997-06-26
ZA9610510B (en) 1998-06-15
ATE471944T1 (de) 2010-07-15
EP0866800A2 (de) 1998-09-30
BG64563B1 (bg) 2005-07-29
AR004382A1 (es) 1998-11-04
CZ184698A3 (cs) 1998-09-16
PT866800E (pt) 2005-01-31
NZ324691A (en) 1999-11-29
CO4750840A1 (es) 1999-03-31
JP3939354B2 (ja) 2007-07-04
KR20000064400A (ko) 2000-11-06
IL166853A (en) 2013-03-24
PL186721B1 (pl) 2004-02-27
CN1127514C (zh) 2003-11-12
TW474946B (en) 2002-02-01
EP1593686B1 (de) 2010-06-23
CZ296908B6 (cs) 2006-07-12
KR100463739B1 (ko) 2005-02-28
WO1997022621A2 (en) 1997-06-26
HUP0000172A2 (en) 2000-07-28
TR199801102T2 (xx) 1998-12-21
SK285286B6 (sk) 2006-10-05
HU228275B1 (en) 2013-02-28
NO982711L (no) 1998-06-12
MY114327A (en) 2002-09-30
RU2182911C2 (ru) 2002-05-27
IL124342A (en) 2005-06-19
PL327175A1 (en) 1998-11-23
BR9611987A (pt) 1999-02-17

Similar Documents

Publication Publication Date Title
DE69609678T2 (de) Synchronisiervorrichtung-Kupplung-Anordnung
DE69622196T2 (de) Motorträgeranordnung
DK0825860T3 (da) Præpart
NO954600D0 (no) Transportkjölesystem
FI973503A0 (fi) Fukopeptidejä
ATA135896A (de) Skibob
FI970168A (fi) Peptidejä
DK0760210T3 (da) Nultids-klemmeindretning
BR9606756A (pt) Peptídeo
NO981052D0 (no) Peptidderivater
ATE198470T1 (de) Alkenyl-benzoylguanidine
DK0866800T3 (da) Antineoplastiske peptider
NO981051D0 (no) Peptidderivater
ATE240972T1 (de) Cyclopeptolide
FIU950092U0 (fi) Asklock
ATA119896A (de) Scheibenmähwerk
KR970013941U (ko) 납골단지
BR1100812A (pt) Peptìdeo
SE9504467D0 (sv) Peptide
BR7500363U (pt) Formulário
JP2631972B2 (ja) Hoosumakitorisochi
FI2033U1 (fi) Dragdon
FI2298U1 (fi) Pintamuokkausjyrsin
KR960030307U (ko) 다시
NO951804D0 (no) Turnus-oversiktsanordning